Spartan Wealth Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.3M Buy
15,778
+586
+4% +$691K 1.46% 12
2026
Q2
$18.2M Buy
15,192
+1,036
+7% +$1.06M 1.49% 13
2026
Q1
$13M Buy
+14,156
New +$14.4M 1.14% 16

Other funds holding LLY

Spartan Wealth Advisory Services's LLY Position: Q3 2026 in Review

Spartan Wealth Advisory Services increased its Eli Lilly (LLY) stake by 3.9% in Q3 2026, buying an estimated $691K and bringing the position to 15,778 shares worth $18.3M. The position accounts for 1.46% of the portfolio, ranked #12.

Spartan Wealth Advisory Services first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Spartan Wealth Advisory Services held 15,778 shares of Eli Lilly worth $18.3M as of Q3 2026.
  • Spartan Wealth Advisory Services bought 586 Eli Lilly shares in Q3 2026, an estimated $691K.
  • Eli Lilly made up 1.46% of Spartan Wealth Advisory Services's portfolio in Q3 2026, its #12 holding.
  • Spartan Wealth Advisory Services first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Spartan Wealth Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.